Alector (ALEC) Stock Forecast & Price Target

Compare

510 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ALEC Analyst Ratings

Hold

1 Buy

5 Hold

2 Sell

Based on 8 analysts giving stock ratings to

Alector

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ALEC Stock 12 Month Forecast

Average Price Target

$2.06

▲(68.85% Upside)

Based on 8 Wall Street analysts offering 12 month price targets for Alector in the last 3 months. The average price target is $2.06 with a high forecast of $5.00 and a low forecast of $0.75. The average price target represents a 68.85% change from the last price of $1.22.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"6":"$6","-1":"-$1","0.75":"$0.75","2.5":"$2.5","4.25":"$4.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$5.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.06,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$2.06</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$0.75</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,0.75,2.5,4.25,6],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.23,1.52,1.81,2.0999999999999996,2.3899999999999997,2.6799999999999997,2.9699999999999998,3.26,3.55,3.84,4.13,4.42,4.709999999999999,{"y":5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.23,1.2938461538461539,1.3576923076923078,1.4215384615384616,1.4853846153846155,1.5492307692307694,1.613076923076923,1.676923076923077,1.7407692307692308,1.8046153846153847,1.8684615384615386,1.9323076923076923,1.9961538461538462,{"y":2.06,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.23,1.1930769230769231,1.156153846153846,1.1192307692307693,1.0823076923076922,1.0453846153846154,1.0084615384615385,0.9715384615384616,0.9346153846153846,0.8976923076923077,0.8607692307692307,0.8238461538461539,0.786923076923077,{"y":0.75,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2.51,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.89,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.66,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.64,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.16,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.22,"date":1746057600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1.38,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.42,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.45,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.59,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.47,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.23,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$5.00

Average Price Target$2.06

Lowest Price Target$0.75

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Andrew Fein

H.C. Wainwright

Buy

309.84%

Upside

Reiterated

12/03/25

H.C. Wainwright Remains a Buy on Alector (ALEC)We reiterate our Buy ratings on Alnylam, Biogen, Arrowhead, Denali, Prothena, AC Immune, Voyager, and Alector.

Graig Suvannavejh

Mizuho Securities

$3.5→$1.5

Hold

22.95%

Upside

Downgraded

11/19/25

Mizuho Securities downgrades Alector (ALEC) to a Hold

Sean Laaman

Morgan Stanley

$1.5→$0.75

Sell

-38.52%

Downside

Reiterated

11/17/25

Alector's Strategic and Financial Challenges Prompt Sell Rating Amid Clinical Setbacks

Myles Minter

William Blair

―

Hold

―

Reiterated

11/07/25

Cautious Outlook on Alector Amid Strategic Shift and Uncertain Clinical Prospects

Alec Stranahan

Bank of America Securities

Sell

-18.03%

Downside

Reiterated

11/07/25

Analysts Conflicted on These Healthcare Names: Alector (NASDAQ: ALEC), Arcellx Inc (NASDAQ: ACLX) and Astrana Health (NASDAQ: ASTH)We reiterate Underperform and $1 PO as we lower OpEx in the near-term and raise OpEx in the long-term

Yaron Werber

TD Cowen

―

Hold

―

Reiterated

11/06/25

Cautious Hold on Alector Amid Strategic Shift and Long-term FocusWe are on the sidelines given few near-term catalysts. PROGRESS-AD Ph2 Interim Next Major Catalyst After INFRONT-3 Miss, PGRN Mechanism Now Uncertain – On ABC Program, AL137 IND In '26 Q3 update pivots focus towards the preclinical Alector Brain Carrier (ABC) platform after clear failure of Ph3 INFRONT-3, leading to latozinemab discontinuation. Anti-amyloid β ABC AL137, first described at R&D day in Sept, is now the lead candidate for AD with IND filing planned for '26; clinical entry for AL050 (GCase-ERT Disease is planned for '27.

Thomas Shrader

BTIG

―

Hold

―

Downgraded

10/22/25

Alector downgraded to Neutral from Buy at BTIGAlector downgraded to Neutral from Buy at BTIG

Pete Stavropoulos

Cantor Fitzgerald

―

Hold

―

Downgraded

10/21/25

Cantor Fitzgerald downgrades Alector (ALEC) to a HoldWe are downgrading ALEC to Neutral, as the INFRONT-3 trial of latozinemab in FTD-GRN failed to meet its primary endpoint (CDR+NACC FTLD-SB), with no directly positive benefit. In addition, other than normalizing PGRN levels, there was no treatment effect on key biomarkers (GFAP , NfL) and vMRI.

Paul Matteis

Stifel Nicolaus

Hold

63.93%

Upside

Reiterated

08/12/25

Stifel Nicolaus Remains a Hold on Alector (ALEC)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Andrew Fein

H.C. Wainwright

Buy

309.84%

Upside

Reiterated

12/03/25

H.C. Wainwright Remains a Buy on Alector (ALEC)We reiterate our Buy ratings on Alnylam, Biogen, Arrowhead, Denali, Prothena, AC Immune, Voyager, and Alector.

Graig Suvannavejh

Mizuho Securities

$3.5→$1.5

Hold

22.95%

Upside

Downgraded

11/19/25

Mizuho Securities downgrades Alector (ALEC) to a Hold

Sean Laaman

Morgan Stanley

$1.5→$0.75

Sell

-38.52%

Downside

Reiterated

11/17/25

Alector's Strategic and Financial Challenges Prompt Sell Rating Amid Clinical Setbacks

Myles Minter

William Blair

―

Hold

―

Reiterated

11/07/25

Cautious Outlook on Alector Amid Strategic Shift and Uncertain Clinical Prospects

Alec Stranahan

Bank of America Securities

Sell

-18.03%

Downside

Reiterated

11/07/25

Yaron Werber

TD Cowen

―

Hold

―

Reiterated

11/06/25

Thomas Shrader

BTIG

―

Hold

―

Downgraded

10/22/25

Alector downgraded to Neutral from Buy at BTIGAlector downgraded to Neutral from Buy at BTIG

Pete Stavropoulos

Cantor Fitzgerald

―

Hold

―

Downgraded

10/21/25

Paul Matteis

Stifel Nicolaus

Hold

63.93%

Upside

Reiterated

08/12/25

Stifel Nicolaus Remains a Hold on Alector (ALEC)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Alector

1 Month

xxx

Success Rate

7/15 ratings generated profit

Average Return

-4.48%

reiterated a xxx

rating 7 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 46.67% of your transactions generating a profit, with an average return of -4.48% per trade.

3 Months

xxx

Success Rate

6/15 ratings generated profit

Average Return

-10.19%

reiterated a xxx

rating 7 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 40.00% of your transactions generating a profit, with an average return of -10.19% per trade.

1 Year

Andrew FeinH.C. Wainwright

Success Rate

3/15 ratings generated profit

Average Return

-42.43%

reiterated a buy rating 7 days ago

Copying Andrew Fein's trades and holding each position for 1 Year would result in 20.00% of your transactions generating a profit, with an average return of -42.43% per trade.

2 Years

xxx

Success Rate

2/15 ratings generated profit

Average Return

-53.87%

reiterated a xxx

rating 7 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 13.33% of your transactions generating a profit, with an average return of -53.87% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ALEC Analyst Recommendation Trends

Rating

Aug 25

Sep 25

Oct 25

Nov 25

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ALEC has received 4 Buy Ratings, 12 Hold Ratings, and 2 Sell Ratings. ALEC average Analyst price target in the past 3 months is 2.06.

Each month's total comprises the sum of three months' worth of ratings.

ALEC Financial Forecast

ALEC Earnings Forecast

Next quarter’s earnings estimate for ALEC is -$0.39 with a range of -$0.50 to -$0.28. The previous quarter’s EPS was -$0.34. ALEC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year ALEC has Performed in-line its overall industry.

ALEC Sales Forecast

Next quarter’s sales forecast for ALEC is $2.38M with a range of $0.00 to $3.51M. The previous quarter’s sales results were $3.26M. ALEC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year ALEC has Performed in-line its overall industry.

ALEC Stock Forecast FAQ

What is ALEC’s average 12-month price target, according to analysts?

Based on analyst ratings, Alector Inc’s 12-month average price target is 2.06.

What is ALEC’s upside potential, based on the analysts’ average price target?

Alector Inc has 68.85% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is ALEC a Buy, Sell or Hold?

Alector Inc has a consensus rating of Hold which is based on 1 buy ratings, 5 hold ratings and 2 sell ratings.

What is Alector Inc’s price target?

The average price target for Alector Inc is 2.06. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $5.00 ,the lowest forecast is $0.75. The average price target represents 68.85% Increase from the current price of $1.22.

What do analysts say about Alector Inc?

Alector Inc’s analyst rating consensus is a Hold. This is based on the ratings of 8 Wall Streets Analysts.

How can I buy shares of ALEC?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Alector (ALEC) Stock Forecast & Price Target

ALEC Analyst Ratings

ALEC Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Alector

ALEC Analyst Recommendation Trends

ALEC Financial Forecast

ALEC Earnings Forecast

ALEC Sales Forecast

ALEC Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts